Asthma Clinical Trials in Chicago, IL

13 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Chicago Asthma School-Directed Child-Centered Assessment and Dissemination of Evidence	N/A	University of Chicago	2 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)	—	Duke University	2 mi
Technology-Enhanced Asthma Care in Children at Clinic and Home Study	N/A	Ann & Robert H Lurie Children's Hospital of Chicago	2 mi
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)	Phase 3	Sanofi	2 mi
Registry of Asthma Characterization and Recruitment 3 (RACR3)	—	National Institute of Allergy and Infectious Diseases (NIAID)	2 mi
Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study	Phase 2	Rajesh Kumar	2 mi
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age	—	Ann & Robert H Lurie Children's Hospital of Chicago	2 mi
Protocol CAUSE-03 / CHEETAH	—	National Institute of Allergy and Infectious Diseases (NIAID)	2 mi
Inhaler Trainer Efficacy Study	N/A	Koronis Biomedical Technologies	2 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma	Phase 3	AstraZeneca	10 mi
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma	Phase 2	Eli Lilly and Company	13 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma	Phase 3	Teva Branded Pharmaceutical Products R&D LLC	13 mi
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma	Phase 2	Incyte Corporation	16 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.